Open Access Government produces compelling and informative news, publications, eBooks, and academic research articles for the public and private sector looking at health, diseases & conditions, workplace, research & innovation, digital transformation, government policy, environment, agriculture, energy, transport and more.
Home Search
COVID-19 - search results
If you're not happy with the results, please do another search
Scientists saw COVID mutating in patient after convalescent plasma
UK based scientists witnessed how COVID-19 can mutate in a highly vulnerable patient, even when that person is undergoing convalescent plasma treatment.
Scientists invent AI that creates COVID vaccine candidates within seconds
Scientists usually take months to analyse potential mutations of the virus, but this new AI can create COVID vaccine candidates within seconds.
UK collaboration will revolutionise rare disease treatment
The Medicines Manufacturing Innovation Centre (MMIC) has developed a scalable, sustainable and more cost-effective way to manufacture oligonucleotides and treat rare diseases.
97.2% of in-person COVID test results returned the next day
NHS Test and Trace turnaround times continue to rise as 97.2% of in-person COVID test results are returned the next day.
European Commission presents Europe’s Beating Cancer Plan
The European Commission has announced its Europe's Beating Cancer Plan which sets out a new EU approach to cancer prevention, treatment and care.
Innovate UK invests £900k into cloud-based pharmacy dispensary software
Innovate UK has invested a further £900k of funding into Titan, a cloud-based medicine dispensary software for pharmacies.
Patient flow and bed management: How does your Trust manage it?
Paul Barrett, TeleTracking UK, explains how automating patient flow and bed management in real-time can transform hospital operations, free up time for nurses to care, reduce stress on caregivers and importantly improve patient outcomes.
Data finds 300mg of coffee can solve short term cognitive impairment
Professor Renata Riha, at the Edinburgh Department of Sleep Medicine, released new data about how coffee can balance short term cognitive impairment - as experienced by sleep deprived people, or shift pattern workers.
Sputnik V vaccine is 91.6% effective against COVID
Interim data from Phase 3 clinical trials show that Russia's Sputnik V vaccine is capable of a 91.6% efficacy against COVID-19.
Coronavirus-related business interruption insurance claims
Jade Brooks, an associate solicitor at Blaser Mills Law, responds to The Supreme Court’s ruling on coronavirus-related business interruption insurance claims and discusses what it means for policyholders.
Data shows young, Black adults twice as likely to die after heart transplant
The American Heart Association found that young, Black adults are more than twice as likely to die in the first year after a heart transplant - in comparison to non-Black transplant recipients of the same age.
How to handle vaccine hesitancy at work
Alan Price, CEO at BrightHR, discusses how employers and HR departments can handle vaccine hesitancy in the workplace.
All UK adults could be offered COVID vaccine by May
According to recent reports, all UK adults could have their first dose of the COVID vaccine by May, 2021 - opening up the potential of a real summer.
High infection numbers can undo our vaccination programmes
The vaccine roll out gives hope of a return to some form of normality, but current high COVID-19 infection numbers put the success of vaccination programmes at risk. Professor Martin Michaelis and Dr Mark Wass of University of Kent’s School of Biosciences explain why.
UK Government allocates £50 million to support students during pandemic
The UK Government has allocated an additional £50 million to support students facing financial pressures from the pandemic.
UK purchases additional 40 million doses of Valneva vaccine
The UK government has announced that it has secured early access to a further 40 million doses of the Valneva COVID-19 vaccine.
Johnson & Johnson vaccine has 66% efficiency in one dose
New clinical trial data shows that the Johnson & Johnson vaccine is able to give 66% protection against COVID in one dose - with an 85% efficiency at the standard double-dose.
Three ways to solve the logistical challenges of giving COVID vaccines
An anonymous Doctor explains their ideas for how the NHS could tackle the significant logistical challenges of giving COVID vaccines.
Horizon Europe reveals five main missions for new funding
The new Horizon Europe programme will pick up where Horizon 2020 left off, with five main missions - cancer, climate change, marine environment, smart cities and food security.
Novavax vaccine is 85.6% efficient against UK COVID mutation
Phase Three data from the UK trial shows that Novavax still works powerfully against the UK mutation, with a less intense impact on the South African mutation at 60%.
